logo-loader

Motif Bio PLC

Receive alerts
Market:
AIM
Market Cap:
£2.27 m
Price
0.66 GBX
Change
-2.69%
52 weeks high
44.90
52 weeks low
0.45

In brief

Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.

Deep dive We explore the investor case for growth companies

Snapshot

Motif is confident there is a path to market for iclaprim, it will require a company with deeper pockets to take the putative treatment further.